FeesSafety
Pluang+

VolitionRx advances with validated sepsis and cancer tests, new licensing deals, and $5M debt cut in 2026

Market News
17 Nov 2026, 16:31 WIB
PRNewsWire
View Source
Bullish
VolitionRx advances with validated sepsis and cancer tests, new licensing deals, and $5M debt cut in 2026

VolitionRx reported significant progress in 2026, validating its Nu.Q® platform for sepsis and early-stage cancer detection with peer-reviewed studies and government programs. The company expanded its Fujifilm agreement to include feline cancer testing and is in talks with over a dozen diagnostic firms for licensing deals. Financially, VolitionRx grew revenue by 134%, reduced operating costs by 13%, and cut convertible note debt by over $5 million. Upcoming milestones include publishing a feline lymphoma study, advancing reimbursement submissions, and finalizing licensing agreements to drive commercial growth.

VolitionRx's 134% revenue growth in 2026 provides context for readers following the company. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 17, 2026 21:01 WIB: out of 150 priced US health stocks, 40 rose and 103 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 8.68 with a +2.12% change and GH (Guardant Health Inc.) at USD 146.98 with a +2.05% change, while NVO (Novo Nordisk A/S) traded at USD 40.81 with a -1.90% change and 94% sell order activity on Pluang.

More News

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
1 hour ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
1 hour ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
1 hour ago
Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan, with over 25 years in financial technology including roles at Goldman Sachs and Coinbase, has joined Dune as Director of Engineering. He will lead the engineering efforts behind Dune Market Data Feeds, which provide real-time trade and liq...

Others
Bullish
1 hour ago
BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock, Inc. has increased its total voting rights in ICG PLC to 5.16% as of November 13, 2026, up from 5.17% previously reported. This includes 5.08% voting rights attached to shares and 0.08% through financial instruments. The notification was o...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App